Healthcare · Pharmaceutical expenditure
Iran's pharmaceutical expenditure accounts for 1.05 % GDP of GDP in 2026, ranking 109th out of 197 countries. This relatively low share is due to a well-developed domestic generic drug industry, which covers about 97% of local demand, keeping costs lower compared to import-dependent markets.
Data for 2026 · unit: % GDP
Position
#109 / 197
Iran world ranking
Country position on the scale from last to first place for this indicator.
IR
#109
#197#1
Trend
Change over time
Change in indicator over the available period.
0.70
1990
0.80
2000
0.90
2010
1.10
2020
1.05
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Iran stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Iran — how much?
Based on 2026 data — 1.05 % GDP. This is rank #109 out of 197 countries.
What is Iran's rank by Pharmaceutical expenditure?
Iran ranks #109 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Iran?
Over the available period the indicator changed from 0.70 to 1.05 % GDP.